Human IFITM3 restricts chikungunya virus and Mayaro virus infection and is susceptible to virus-mediated counteraction

Sergej Franz; Fabian Pott; Thomas Zillinger; Christiane Schüler; Sandra Dapa; Carlo Fischer; Vânia Passos; Saskia Stenzel; Fangfang Chen; Katinka Döhner; Gunther Hartmann; Beate Sodeik; Frank Pessler; Graham Simmons; Jan Felix Drexler; Christine Goffinet

doi:10.26508/lsa.202000909

Research Article

Open Access

Human IFITM3 restricts chikungunya virus and Mayaro virus infection and is susceptible to virus-mediated counteraction

Sergej Franz, View ORCID ProfileFabian Pott, View ORCID ProfileThomas Zillinger, View ORCID ProfileChristiane Schüler, Sandra Dapa, View ORCID ProfileCarlo Fischer, Vânia Passos, Saskia Stenzel, View ORCID ProfileFangfang Chen, Katinka Döhner, Gunther Hartmann, View ORCID ProfileBeate Sodeik, Frank Pessler, Graham Simmons, Jan Felix Drexler, View ORCID ProfileChristine Goffinet Correspondence email

Sergej Franz

1Institute of Experimental Virology, TWINCORE Centre for Experimental and Clinical Infection Research, a Joint Venture Between the Hannover Medical School (MHH) and the Helmholtz Centre for Infection Research (HZI), Hannover, Germany

2Vitalant Research Institute, San Francisco, CA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Fabian Pott

3Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Virology, Berlin, Germany

4Berlin Institute of Health at Charité–Universitätsmedizin Berlin, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Fabian Pott

Thomas Zillinger

5Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, Venusberg-Campus 1, Bonn, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Thomas Zillinger

Christiane Schüler

3Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Virology, Berlin, Germany

4Berlin Institute of Health at Charité–Universitätsmedizin Berlin, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Christiane Schüler

Sandra Dapa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Carlo Fischer

3Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Virology, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Carlo Fischer

Vânia Passos

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Saskia Stenzel

3Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Virology, Berlin, Germany

4Berlin Institute of Health at Charité–Universitätsmedizin Berlin, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Fangfang Chen

6Research Group Biomarkers for Infectious Diseases, TWINCORE, Centre for Experimental and Clinical Infection Research, a Joint Venture Between the Hanover Medical School (MHH) and the Helmholtz Centre for Infection Research (HZI), Hanover, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Fangfang Chen

Katinka Döhner

7Institute of Virology, Hannover Medical School, Hanover, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gunther Hartmann

3Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Virology, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Beate Sodeik

7Institute of Virology, Hannover Medical School, Hanover, Germany

8Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Beate Sodeik

Frank Pessler

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Graham Simmons

2Vitalant Research Institute, San Francisco, CA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jan Felix Drexler

3Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Virology, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christine Goffinet

3Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Virology, Berlin, Germany

4Berlin Institute of Health at Charité–Universitätsmedizin Berlin, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Christine Goffinet
For correspondence: christine.goffinet@charite.de

Published 2 June 2021. DOI: 10.26508/lsa.202000909

Article
Figures & Data
Info
Metrics
Reviewer Comments
PDF

Statistics from Altmetric.com

Article usage

Article usage: June 2021 to September 2024

	Abstract	Full	Pdf
Jun 2021	28	344	214
Jul 2021	45	119	75
Aug 2021	1	98	50
Sep 2021	5	74	46
Oct 2021	1	81	60
Nov 2021	3	86	51
Dec 2021	1	46	38
Jan 2022	2	51	23
Feb 2022	3	46	43
Mar 2022	8	48	31
Apr 2022	2	37	51
May 2022	3	78	81
Jun 2022	2	49	56
Jul 2022	3	37	24
Aug 2022	0	67	39
Sep 2022	4	48	45
Oct 2022	1	52	30
Nov 2022	4	42	45
Dec 2022	1	20	9
Jan 2023	3	41	21
Feb 2023	11	42	61
Mar 2023	1	54	31
Apr 2023	4	46	37
May 2023	8	25	16
Jun 2023	1	23	18
Jul 2023	3	45	27
Aug 2023	5	20	16
Sep 2023	7	28	15
Oct 2023	3	44	28
Nov 2023	8	49	16
Dec 2023	6	38	81
Jan 2024	2	46	63
Feb 2024	8	32	32
Mar 2024	3	40	37
Apr 2024	3	44	32
May 2024	4	37	23
Jun 2024	1	50	31
Jul 2024	5	28	33
Aug 2024	7	28	26
Sep 2024	4	6	10

PreviousNext

Download PDF

Email Article

Thank you for your interest in spreading the word on Life Science Alliance.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Human IFITM3 restricts chikungunya virus and Mayaro virus infection and is susceptible to virus-mediated counteraction

Message Subject (Your Name) has sent you a message from Life Science Alliance

Message Body (Your Name) thought you would like to see the Life Science Alliance web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Human IFITM3 restricts alphaviruses

Sergej Franz, Fabian Pott, Thomas Zillinger, Christiane Schüler, Sandra Dapa, Carlo Fischer, Vânia Passos, Saskia Stenzel, Fangfang Chen, Katinka Döhner, Gunther Hartmann, Beate Sodeik, Frank Pessler, Graham Simmons, Jan Felix Drexler, Christine Goffinet

Life Science Alliance Jun 2021, 4 (7) e202000909; DOI: 10.26508/lsa.202000909

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Human IFITM3 restricts alphaviruses

Life Science Alliance Jun 2021, 4 (7) e202000909; DOI: 10.26508/lsa.202000909

Share This Article:

Tweet Widget

In this Issue

Volume 4, No. 7

July 2021

Table of Contents
Cover (PDF)
About the Cover
Masthead (PDF)

Jump to section

Article
Figures & Data
Info
Metrics
Reviewer Comments
PDF

Subjects

Immunology
Microbiology, Virology & Host Pathogen Interaction

No related articles found.

Cited By...

No citing articles found.

Google Scholar

Main menu

User menu

Search

Human IFITM3 restricts chikungunya virus and Mayaro virus infection and is susceptible to virus-mediated counteraction

Statistics from Altmetric.com

Article usage

Article usage: June 2021 to September 2024

Citation Manager Formats

In this Issue

Subjects

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Content

For Authors

Other Services

More Information